Early Access — free while we kick the tires
EdgarHawk

Inglis John C

Director

Director
10 filings analyzed · 2 companies · Latest 2025-12-31

Companies

Company Buys Sells Direction
AMERICAN INTERNATIONAL GROUP, INC. AIG 10 0 Net buying
HUNTINGTON BANCSHARES INC /MD/ HBAN 1 0 Net buying

Activity

December 2025
Buy
14 shares
$1,200
Significance 3/10

AIG Director Inglis bought 13 shares at $86.47; mixed track record on timing; company faced -41.8% revenue decline FY-over-FY.

Director John C Inglis purchased 13 shares of AIG at $86.47, a modest transaction adding less than 0.5% to his 2,680-share position. Across his prior five AIG trades, Inglis achieved positive 90-day returns on 2 of 5 buys, indicating inconsistent timing accuracy at this ticker. His cross-ticker track record shows a 40.00% 90-day win rate with an average 90-day return of +0.9%, suggesting marginal predictive value. The underlying company faces material headwinds: FY revenue declined -41.8% year-over-year and AIG was unprofitable over its most recent full fiscal year, though current P/E of 14.16 and the stock's recent +11.7% 30-day rally may reflect market repricing. The transaction size and holding stability do not indicate strategic conviction or portfolio repositioning.

November 2025
Buy
6,506 shares
$99,542
Significance 4/10

Director John C Inglis bought 6,506 shares of HBAN at $15.30 on 2025-11-04, raising holdings to 89,831 shares

Director John C Inglis purchased 6,506 shares at $15.30, a price 0.06% below the current market price of $15.29, yet 16.0% below the 52-week high of $18.20. His holdings increased 7.8% to 89,831 shares following the transaction. However, his cross-ticker track record shows limited predictive power: 10 prior open-market buys averaged only -0.5% return over 30 days and -0.1% over 90 days, with a 90-day win rate of just 37.50%. The stock itself has declined 8.5% over the past 30 days and 3.6% over 90 days, placing the timing of this purchase within a period of downward momentum. Fundamental metrics are modest—the company trades at a P/E of 10.06 with net income of $629.0M against a market cap of $22.3B—but insufficient context exists to determine whether this represents conviction or routine portfolio management at a lower price level.

October 2025
Buy
15 shares
$1,193
Significance 3/10

Director Inglis buys 15 AIG shares at $78.03; small increase to 2,666 holdings as stock down 2.1% in 30d.

Director John C Inglis purchased 15 shares of AIG at $78.03 on 2025-09-30, a modest increase of 0.6% relative to his pre-transaction holdings of 2,651 shares. The transaction occurs as the stock trades at $79.64 and has declined 2.1% over the prior 30 days and 4.3% over 90 days, currently 9.2% below its 52-week high of $87.72. Examining Inglis's prior purchases at AIG shows mixed outcomes: his last four distinct prior buys recorded 90-day returns ranging from -9.4% to +15.9%, with 2 of 4 proving well-timed by the 90-day mark. His cross-ticker track record of 9 prior buys averaged -0.1% over 90 days with only a 37.50% win rate. The fundamental context is challenging: AIG reported a -41.8% annual revenue decline and was unprofitable over its most recent full fiscal year, though recent quarterly revenue was $7.1B and net income was $1.1B on a 13.80 P/E ratio. The small transaction size and modest addition to an existing position offer limited signal clarity about conviction.

August 2025
Buy
653 shares
$50,307
Significance 4/10

Director John C. Inglis buys 653 AIG shares at $77.04; holdings +32.7% but fundamentals show -41.8% revenue decline and negative full-year net income.

Director John C. Inglis purchased 653 shares of AIG at $77.04 on 2025-08-08, increasing his holdings by 32.7% from 1,998 to 2,651 shares. At the prior buy on 2025-06-27, a 30-day return of -5.9% materialized, and his five-transaction history at AIG shows 3 of 4 prior measurable outcomes exhibited positive 90-day returns, suggesting some tendency toward favorable timing at this ticker. However, this purchase occurs against materially deteriorating fundamentals: annual revenue contracted -41.8%, the company was unprofitable on a full-year basis, and the stock has fallen -6.0% over the last 30 days and -5.2% over 90 days despite recent buys. The current price of $78.13 is -10.9% from the 52-week high, placing the trade at a modest discount to recent peaks, but the severity of the revenue decline and negative annual earnings raises questions about the earnings power and durability of the business being acquired.

June 2025
Buy
11 shares
$895
Significance 3/10

Director Inglis buys 10 AIG shares at $85.11; modest accumulation extends mixed timing record at this ticker.

Inglis John C, a director, purchased 10 shares of AIG at $85.11 on 2025-06-27, increasing his holdings by 10 shares to 1,998 shares post-transaction. This is a modest acquisition in isolation. Examining his prior AIG trades reveals a split record: 3 of 5 prior buys showed positive 90-day returns (well-timed), while 2 did not, suggesting inconsistent timing judgment at this ticker. His cross-ticker track record shows 7 prior buys with a 42.86% 90-day win rate, indicating below-average success identifying entry points overall. The company's financial backdrop—annual revenue growth of -41.8% and full-year net income negative over the most recent fiscal year—adds context for why repeated insider buying may reflect tactical positioning rather than a strong fundamental signal.

April 2025
Buy
644 shares
$50,658
Significance 6/10

Director Inglis bought 644 shares across 2 transactions ($50,658.13 total) at blended average $78.64; holdings +47.9%

John C. Inglis, a Director at AIG, executed 2 separate purchases totaling 644 shares for $50,658.13 (blended average $78.64) on May 22, 2024 and March 31, 2025, increasing his holdings by 47.9% from 1,343 to 1,988 shares. The current stock price of $87.72 sits at the 52-week high with a 90-day gain of 20.2%, while AIG's fundamentals remain challenged: the company posted -41.8% annual revenue growth and was unprofitable over its most recent full fiscal year. Among Inglis's prior 5 trades at AIG, 3 exhibited positive 90-day returns (well-timed), but his same-ticker pattern is mixed—two buys generated 90-day losses despite the current price strength. This sustained accumulation during a period of fundamental weakness and mixed historical timing at this ticker warrants observation of whether the director's conviction reflects non-public information or near-term catalysts.

January 2025
Buy
11 shares
$787
Significance 3/10

Director John C Inglis bought 10 AIG shares at $72.16 on 2024-12-30; stock now at $72.98, down 9.4% from 52-week high.

Director John C Inglis purchased 10 shares of AIG at $72.16, a modest transaction adding 0.8% to his 1,343-share position. The purchase occurs with AIG down 2.8% over 30 days and 4.0% over 90 days, and the stock trades 9.4% below its 52-week high of $80.54. Examining his prior AIG purchases, only 1 of 4 completed transactions showed positive 90-day returns (the June 28 buy returned +3.1%), indicating a pattern of weak execution timing at this ticker. His cross-ticker track record shows 5 prior buys with a 25% 90-day win rate and -2.2% average 90-day return, suggesting limited predictive value. The transaction size is minimal relative to his existing AIG holdings and the company's $45.5B market cap, providing limited signal regarding material conviction shifts.

November 2024
Buy
660 shares
$50,002
Significance 5/10

Director Inglis bought 660 AIG shares at $75.76 (11/26), doubling holdings to 1,333 shares; prior AIG buys 0 of 3 well-timed at 90d mark.

John C. Inglis, a Director, purchased 660 shares of AIG at $75.76 on 2024-11-26, increasing his holdings by 98.1% to 1,333 shares. The current price of $76.30 is -5.3% from the 52-week high of $80.54. His prior trades at AIG show a consistent pattern of poor timing at the 90-day horizon: his three measurable prior buys at this ticker achieved 0 of 3 well-timed outcomes, with two of the three purchases followed by 90-day declines (-2.4% and -5.9%). This buy adds to an existing pattern of unfavorable post-purchase performance at this specific security, suggesting limited predictive value in this insider's AIG purchase decisions.

October 2024
Buy
7 shares
$520
Significance 3/10

AIG director Inglis buys 7 shares at $72.76; holding now 673 shares. Stock down 10% from 52-week high.

Director John C Inglis purchased 7 shares of AIG at $72.76 on 2024-09-30, increasing his holdings to 673 shares. The modest position increase of 7 shares (+1.1%) carries minimal weight relative to his overall holdings. His prior purchases at AIG show a consistent pattern of poor timing: 3 prior buys yielded zero positive 90-day outcomes, with cumulative 90-day returns of -2.4%, -5.9%, and -0.9%. The company's fundamentals present a challenging backdrop: net income of $-3,977,000,000.00 in the latest quarter against revenue of $6,560,000,000.00, alongside annual revenue decline of -17.1%. Stock price has declined 10.0% from its 52-week high and 6.0% over the past 30 days, trading at $72.45 as of current market price.

July 2024
Buy
7 shares
$518
Significance 2/10

Director John C. Inglis bought 6 AIG shares at $74.89 on 2024-06-28; modest purchase extends pattern of recent buys with mixed results.

Director Inglis purchased 6 shares at $74.89, a small addition to his holdings that increased them from 659 to 665 shares (+1.0%). This is his third open-market purchase at AIG in four months (prior buys on 2024-05-22 and 2024-03-14), yet the historical timing record at this ticker shows mixed execution: his May purchase has declined 4.6% over 30 days, and his March purchase gained only 30-day but declined 0.9% over 90 days. The stock is currently -4.4% over 30 days and -3.2% over 90 days from the transaction date, placing the June purchase below entry. Across his broader open-market history (2 prior buys at other tickers), his average 90-day return is -0.9% with a 0% win rate, indicating a pattern of buying into weakness that has not subsequently recovered. At the fundamentals level, AIG is a $50.0B market-cap financial services company with -17.1% annual revenue growth and a P/E of 10.35, combining valuation compression with negative organic momentum.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access